Exhibit  31.1

                           CERTIFICATION OF PRESIDENT
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of  PracticeXpert,  Inc. (the "Company")
on Form  10-QSB  for the  period  ending  September  30,  2003 as filed with the
Securities  and  Exchange  Commission  on the date  hereof  (the  "Report"),  I,
Jonathan Doctor, President of the Company, certify, pursuant to Rules 13a-14 and
15-d14 of the Securities  Exchange Act of 1934 (the "Exchange  Act"), as adopted
pursuant to ss.302 of the Sarbanes-Oxley  Act of 2002, that:  1. I have reviewed
this Report;

2.       Based  on my  knowledge,  this  Report  does  not  contain  any  untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances  under which
         such  statements  were made, not misleading  with respect to the period
         covered by this Report;

3.       Based on my knowledge,  the financial  statements,  and other financial
         information  included in this  Report,  fairly  present in all material
         respects the financial condition,  results of operations and cash flows
         of the Company, as of, and for, the periods presented in this Report;

4.       I and the other certifying  officers of the Company are responsible for
         establishing  and  maintaining  disclosure  controls and procedures (as
         defined in Exchange Act Rules  13a-15(e) and 15d-15(e)) for the Company
         and have:

         (a) Designed such disclosure  controls and  procedures,  or caused such
         disclosure   controls  and   procedures   to  be  designed   under  our
         supervision,  to  ensure  that  material  information  relating  to the
         Company, including any consolidated  subsidiaries,  is made known to us
         by others  within  those  entities,  particularly  during the period in
         which this Report is being prepared; (b) Evaluated the effectiveness of
         the Company's  disclosure controls and procedures and presented in this
         Report  our  conclusions  about  the  effectiveness  of the  disclosure
         controls and  procedures,  as of the end of the period  covered by this
         Report based on such  evaluation;  and (c) Disclosed in this Report any
         change in the Company's internal control over financial  reporting that
         occurred during the Company's most recent fiscal quarter (the Company's
         fourth  fiscal  quarter  in the  case of an  annual  report)  that  has
         materially affected,  or is reasonably likely to materially affect, the
         Company's internal control over financial reporting; and

5.       I and the other certifying  officers have disclosed,  based on our most
         recent evaluation of internal control over financial reporting,  to the
         Company's auditors and to the audit committee of the Company's board of
         directors (or persons performing the equivalent functions):

         (a) All significant  deficiencies and material weaknesses in the design
         or operation of internal  control over  financial  reporting  which are
         reasonably  likely to adversely affect the Company's ability to record,
         process, summarize and report financial information; and (b) Any fraud,
         whether or not material,  that involves  management or other  employees
         who have a  significant  role in the  Company's  internal  control over
         financial reporting.


/s/ Jonathan Doctor
--------------------
Jonathan Doctor,
Chief Executive Officer
November 20, 2003